Bitcoin ETF Inflows Rise as Altcoin Fund Demand Dries Up
Bitcoin ETFs attracted $986.9 million in the week ending Sept. 4, while inflows into Ethereum, Solana, XRP, and Hyperliquid funds fell sharply.
Bitcoin ETFs attracted $986.9 million in the week ending Sept. 4, while inflows into Ethereum, Solana, XRP, and Hyperliquid funds fell sharply.
Grayscale's Zcash ETF held $463.2M in assets as ZEC hit $1,185, up 11% in 24 hours.
Zcash briefly traded above $1,000 for the first time in nearly a decade; after a sharp run-up, traders are watching whether the level holds.
Hargreaves Lansdown now offers Bitcoin ETNs to 2 million clients, but only for high earners in taxed accounts, missing the ISA tax window that closed in April.
Bitcoin and Ethereum climbed to multi-month highs amid rate-pause signals and ETF inflows, but prediction markets show low odds for record highs by 2026.
The Senate lost eight voting days in September, reducing floor time for the CLARITY Act and pushing a possible vote to November.
Willy Woo argues Bitcoin's four-year halving cycle may end, shifting to a 6-8 year debt cycle from traditional finance.
Hyperliquid's HYPE token has been added to the Hashdex Nasdaq CME Crypto Index ETF with a 3.4% weighting, becoming its fifth-largest holding.
Grayscale urged the SEC not to introduce new rules for crypto ETFs, arguing existing framework works.
BlackRock's iShares Bitcoin Trust has outperformed Vanguard's S&P 500 ETF since its 2024 launch, gaining 71% versus 66%.
Ethereum fell 3.7% from August high as short-term ETF inflows slowed and whale selling emerged, but long-term structural indicators remain supportive.
Bitcoin gained 25% in August on $3.5B ETF inflows, but September may see a pullback based on past patterns.
Crypto market up 0.87% on Tuesday; Trump rules out nuclear strike on Iran; Bitcoin ETF inflows halt but altcoin ETFs continue; Arbitrum surges 31.3% onβ¦
Ethereum futures hold above VWAP at $2,477.70, with bulls maintaining a mild edge but facing resistance near $2,500.
President Trump added nine pharmaceutical firms to his drug-pricing deal, pledging $19.6 billion in manufacturing. Healthcare stocks continue to rally.